DOCSLIB.ORG

Revised 4/6/10 CURRICULUM VITAE Nathaniel J. Jellinek, M.D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Revised 4/6/10 CURRICULUM VITAE Nathaniel J. Jellinek, M.D Revised 4/6/10 CURRICULUM VITAE Nathaniel J. Jellinek, M.D. Dermatology Professionals, Inc. 1672 South County Trail, Suite 101 East Greenwich, RI 02818 401-885-6647 (phone) 401-885-6639 (fax) E-mail: [email protected] EDUCATION Undergraduate B.A. in American Civilization, Brown University, Providence, RI, 1991-1995 Medical School Course on Multiple Organ Dysfunction Syndrome, University of Massachusetts Medical School, Worcester, MA, 1997 M.D. University of Massachusetts Medical School, Worcester, MA, 1996-2000 Previous Employment Resident Counselor in first year dormitory, Brown University, Providence, RI 1992-1993 Disk Jockey at WBRU, 95.5 FM, Providence, RI ,1991-1995 Teacher at Applewild School of U.S. History and Music, as well as a coach for soccer, basketball, and lacrosse, Fitchburg, MA, 1995-1996 Professional musician in small jazz, salsa, rock/funk groups, with more than 100 performances, 1991-1999 POSTGRADUATE MEDICAL TRAINING Internship Internal Medicine, Saint Vincent Hospital at the Worcester Medical Center, Worcester, MA 2000-2001 Residency Residency in Dermatology, University of Massachusetts, Worcester, MA 2001- 2004 Chief Resident, Division of Dermatology, University of Massachusetts, Worcester, MA 2003-2004 One month elective in Tropical Medicine at the Regional Dermatology Training Center, Moshi, Tanzania April 2004 Fellowship Mohs micrographic surgery, Division of Dermatology, 1 University of Massachusetts, Worcester, MA 2004-2005 Nail Disease, Division of Dermatology, University of Massachusetts, Worcester, MA 2004-2005 HONORS AND AWARDS 1999 Alpha Omega Alpha (University of Massachusetts Medical School) 2000 Merck Award for Academic Excellence (University of Massachusetts Medical School) 1/05 Chosen to attend the American Academy of Dermatology Leadership Forum, Orlando, Florida 1/05 Chosen to attend the American Academy of Dermatology Leadership Training, Orlando, Florida 3/05 Selected and graduated as one of 15 people for the initial one year masters course in academic leadership sponsored by the American Academy of Dermatology 6/06 Teacher of the Year, Department of Dermatology, Brown Medical School, Providence, RI 7/06 Dean’s Teaching Excellence Award, Brown Medical School, Providence, RI 6/07 Teacher of the Year, Department of Dermatology, Brown Medical School, Providence, RI 6/07 Dean’s Teaching Excellence Award, The Warren Alpert Medical School of Brown University, Providence, RI 6/08 Teacher of the Year, Department of Dermatology, Brown Medical School, Providence, RI 6/08 Dean’s Teaching Excellence Award, The Warren Alpert Medical School of Brown University, Providence, RI 6/09 Dean’s Teaching Excellence Award, The Warren Alpert Medical School of Brown University, Providence, RI PROFESSIONAL MEDICAL LICENSURE/CERTIFICATION 1998 USMLE Step 1 2000 USMLE Step 2 2001 USMLE Step 3 2004 Massachusetts State Medical License (# 220846) 2004 Rhode Island State Medical License (#11514) 2004 American Board of Dermatology 2006 Basic Life Support 2006 Advanced Cardiac Life Support 2 ACADEMIC APPOINTMENTS 2004-2005 Instructor, Department of Medicine, Division of Dermatology, University of Massachusetts Medical School 2005-2009 Assistant Professor, Department of Dermatology, The Warren Alpert Medical School of Brown University 2009-present Clinical Assistant Professor, Department of Dermatology, The Warren Alpert Medical School of Brown University 2004-2006 Adjunct Clinical Assistant Professor, Department of Medicine, Division of Dermatology, University of Massachusetts Medical School HOSPITAL APPOINTMENTS 2004-2005 Active Staff, University of Massachusetts Memorial Health Care, Worcester, MA 2005- present Active Staff in Dermatology and Dermatologic Surgery Rhode Island Hospital, Providence, RI OTHER APPOINTMENTS Reviewer 2001-present Journal of the American Academy of Dermatology 2005-2006 Journal of Drugs in Dermatology 2008-present Dermatologic Surgery 2008-present Archives of Dermatology 2009-present Clinical and Experimental Dermatology 2009-present British Journal of Dermatology Journal Appointments 2003-2008 Section editor, Book & Media Reviews, Journal of the American Academy of Dermatology 2005-2008 Associate editor, Journal of the American Academy of Dermatology 2008-present Editorial Board, Journal of the American Academy of Dermatology HOSPITAL COMMITTEES 2003-2004 Institute for Healthcare Improvement (IHI) task force: a pilot project between Family Practice and Dermatology with the goal of improving 3 access and clinic performance 7/2003-10/2003 Co-chair, Internal Review for Department of Internal Medicine and Subspecialties, University of Massachusetts, Worcester, MA OTHER COMMITTEES 2/2007-11/08 Member, Bioterrorism/Disaster Preparedness Task Force, American Academy of Dermatology 2/2007-2/2011 Member, Sulzberger Institute for Dermatologic Ed. Committee, American Academy of Dermatology 10/2007-10/2010 Member, New Technologies Work Group, American Society of Dermatologic Surgery 3/09- Member, Annual Meeting Evaluation Task Force, American Academy of Dermatology MEMBERSHIP IN SOCIETIES 1999-2005 Massachusetts Medical Society 2000-2005 Worcester Medical Society 2001-present New England Dermatological Society 2001-present American Academy of Dermatology 2004-present Council for Nail Disorders 2004-present American Society for Dermatologic Surgery 2005-present American College of Mohs Surgery (formerly American College of Mohs Micrographic Surgery and Cutaneous Oncology) VOLUNTEER SERVICE 1992 Women’s shelter, children’s playroom (Providence, RI) 1995 Recovery room for Ambulatory Surgery, Rhode Island Hospital (Providence, RI) 1996-1998 Flu shot program for underserved population (Worcester, MA) 1996-1998 Free health clinics at local church and community center (Worcester, MA) 2001, 2002 Toys for Tots children’s fair at Greendale Mall (Worcester, MA) 2002-2003 Annual free skin cancer screening at University of Massachusetts, Worcester, MA 2004 Co-organizer, annual free skin cancer screening at University of Massachusetts, Worcester, MA 2005 Organizer, annual free skin cancer screening at University of Massachusetts, Worcester, MA 4 & 5/2007 Skin Cancer screening, Transplant Population, Department of Dermatology, Brown Medical School, Providence, RI 8/10/09 Skin Cancer screening, Gillette Stadium, Foxboro, MA 5/15/10 Skin Cancer screening, Dermatology Professionals, Inc., East Greenwich, RI PEER-REVIEWED PUBLICATIONS 4 1. Jellinek NJ, Primary malignant tumors of the nail unit. Adv Dermatol 2005;21:33- 64. 2. Kannler C, Jellinek N, Maloney ME. Surgical Pearl: The use of endarterectomy scissors in dermatologic surgery. J Am Acad Dermatol 2005;53:873-4. 3. Zeikus, P, Maloney ME, Jellinek NJ. Advancement flap for the reconstruction of nasal alar and lateral tip defects. J Am Acad Dermatol 2006 Dec;55(6):1032-5. 4. Jellinek NJ. Nail surgery: practical tips and treatment options. Dermatol Ther. 2007 Jan-Feb;20(1):68-74. 5. Jellinek NJ. Nail matrix biopsy of longitudinal melanonychia:diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol, 2007 May;56(5):803-810. 6. Telang GH, Jellinek NJ. Multiple calcified subungual epidermoid inclusions. J Am Acad Dermatol. 2007 Feb;56(2):336-9. 7. Harwood M, Telang G, Robinson-Bostom L, Jellinek NJ. Melanoma and squamous cell carcinoma on different nails of the same hand. J Am Acad Dermatol. 2008 Feb; 58(2):323-325. 8. Shimizu I, Jellinek NJ, Dufresne RG, Li T, Devarajan K, Perlis C. Multiple antithrombotic agents increase the risk of postoperative hemorrhage in dermatologic surgery. J Am Acad Dermatol. 2008 May;58(5):810-6. 9. Dufresne R, Cruz A, Zeikus P, Perlis C, Jellinek NJ. Dermabrasion for Actinic Cheilitis. Dermatol Surg. 2008;34:848-850. 10. Naylor EM, Ruben BS, Robinson-Bostom L, Telang GH, Jellinek NJ. Subungual blue nevus with combined phenotypic features. J Am Acad Dermatol. 2008 Jun;58(6):1021-4. 11. Jellinek NJ. A Simplified Approach to Diagnosis of Longitudinal Melanonychia. Melanoma Letter 2008;26(1):1-4. 12. Jellinek NJ, Daniel CR III; Paronychia. BMJ In Practice (Online database available at: http://bmjreview.epocrates.com/dx/full.do?ActiveSectionId=11&MonographId=350) 2008. 13. Hall R, Jellinek NJ, Telang G, Robinson-Bostom L. Lichen Planus of the Nail Matrix with Predominant Plasma Cell Infiltrate. J Cutan Pathol. 2008 Oct 35; Suppl 1:14-6. 14. Collins SC, Dufresne RG Jr, Jellinek NJ. The Bilobed Transposition Flap for Single- Staged Repair of Large Surgical Defects Involving the Nasal Ala. Dermatol Surg. 2008 Oct;34(10):1379-1386. 15. Collins SC, Cordova K, Jellinek NJ. Alternatives to complete nail plate avulsion. J Am Acad Dermatol 2008 Oct;59(4):619-26. 16. Collins SC, Jellinek NJ. Matrix biopsy of longitudinal melanonychia and erythronychia: A step-by-step approach. Cosmetic Surgery May, 2009. 17. D’Agostino M, Cinelli C, Willard R, Hoffman J, Jellinek NJ, Robinson-Bostom L. Merkel Cell Carcinoma: A Case Series and Histopathologic Examination. J Am Acad Dermatol 2010;62:463-8. 18. Collins SC, Cordova K, Jellinek NJ. Midline and paramedian longitudinal nail biopsy. J Am Acad Dermatol 2010;62:627-36. 19. Criscione V, Telang GH, Jellinek NJ. Onychopapilloma presenting as longitudinal leukonychia. J Am Acad Dermatol. Accepted 6/1/09 20. Jellinek NJ, Longitudinal Erythronychia: Suggestions for Evaluation and Management. J Am Acad Dermatol, Accepted 8/09. 5 OTHER PUBLICATIONS 1. Jellinek NJ, Iotaderma #104 J Am Acad Dermatol 2002;47:438. 2. Jellinek NJ, Book Review for Dermatopathology, J Am Acad Dermatol 2003;49:969. 3. Jellinek
Load more

Recommended publications
  • Research Article
    z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 11, Issue, 12, pp.8946-8949, December, 2019 DOI: https://doi.org/10.24941/ijcr.37495.12.2019 ISSN: 0975-833X RESEARCH ARTICLE SKIN: A WINDOW FOR THYROID DISEASE 1Neethu Mary George, 2,*Amruthavalli Potlapati and 3Narendra Gangaiah 1 Resident, Department of Dermatology, Sri Siddhartha Medical College, Karnataka 2Assistant Professor, Department of Dermatology, Sri Siddhartha Medical College, Karnataka 3Professor and HOD, Department of Dermatology, Sri Siddhartha Medical College, Karnataka ARTICLE INFO ABSTRACT Article History: Introduction: Endocrine conditions form a major bulk of those visiting physicians and most of the Received 24th September, 2019 conditions warrant immediate and long term treatment which otherwise can indirectly affect all the Received in revised form organ systems and adversely affect the ‘health’ of a person. Thyroid diseases are one of the most 28th October, 2019 common endocrinological conditions with varying skin and appandageal manifestations. Skin is an Accepted 15th November, 2019 organ that is visible to naked eyes and can at times show certain manifestations which point to an Published online 31st December, 2019 underlying disease. Unless the clinician has high index of suspicion, such conditions can go undetected. Hence it becomes imperative for clinicians and Dermatologists to have an idea about the Key Words: cutaneous manifestations of endocrinological conditions and hence the study assess the skin Hyperthyroid, Hypothyroid, Cutaneous manifestations in recently detected hyper and hypothyroid patients. Objectives: To evaluate the cutaneous, hair and nail findings and associated conditions in acquired thyroid disorders. Manifestations, Pincer Nail.
    [Show full text]
  • C.O.E. Continuing Education Curriculum Coordinator
    CONTINUING EDUCATION All Rights Reserved. Materials may not be copied, edited, reproduced, distributed, imitated in any way without written permission from C.O. E. Continuing Education. The course provided was prepared by C.O.E. Continuing Education Curriculum Coordinator. It is not meant to provide medical, legal or C.O.E. professional services advice. If necessary, it is recommended that you consult a medical, legal or professional services expert licensed in your state. Page 1 of 199 Click Here To Take Test Now (Complete the Reading Material first then click on the Take Test Now Button to start the test. Test is at the bottom of this page) 5 hr. Nail Structure and Growth & TCSG Health and Safety Outline Why Study Nail Structure and Growth? • The Natural Nail • Nail Anatomy • Nail Growth • Know Your Nails Objectives After completing this section, you should be able to: C.O.E.• Describe CONTINUING the structure and composition of nails. EDUCATION • Discuss how nails grow. • Identify diseases and disorders of the nail All Rights Reserved. Materials may not be copied, edited, reproduced, distributed, imitated in any way without written permission from C.O. E. Continuing Education. The course provided was prepared by C.O.E. Continuing Education Curriculum Coordinator. It is not meant to provide medical, legal or professional services advice. If necessary, it is recommended that you consult a medical, legal or professional services expert licensed in your state. 1 CONTINUING EDUCATION All Rights Reserved. Materials may not be copied, edited, reproduced, distributed, imitated in any way without written permission from C.O.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Immunologic Adverse Reactions of Β-Blockers and the Skin (Review)
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 18: 955-959, 2019 Immunologic adverse reactions of β-blockers and the skin (Review) ALIN LAURENTIU TATU1, ALINA MIHAELA ELISEI1, VALENTIN CHIONCEL2, MAGDALENA MIULESCU3 and LAWRENCE CHUKWUDI NWABUDIKE4 1Medical and Pharmaceutical Research Unit/Competitive, Interdisciplinary Research Integrated Platform ‘Dunărea de Jos’, ReForm-UDJG; Research Centre in the Field of Medical and Pharmaceutical Sciences, Faculty of Medicine and Pharmacy, Department of Pharmaceutical Sciences, ‘Dunărea de Jos’ University of Galați, 800010 Galati; 2Department of Cardio-Thoracic Pathology, Faculty of Medicine, ‘Carol Davila’ University of Medicine and Phamacy, 050474 Bucharest; 3Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, ‘Dunarea de Jos University’ of Galati, 800010 Galati; 4Department of Diabetic Foot Care, ‘Prof. N. Paulescu’ National Institute of Diabetes, 011233 Bucharest, Romania Received September 11, 2018; Accepted November 16, 2018 DOI: 10.3892/etm.2019.7504 Abstract. β-Blockers are a widely utilised class of medica- use, as well as possible therapeutic approaches to these. This tion. They have been in use for a variety of systemic disorders short review will focus on those dermatoses resulting from including hypertension, heart failure and intention tremors. β-blocker use, which have an immunologic basis. Their use in dermatology has garnered growing interest with the discovery of their therapeutic effects in the treatment of haemangiomas, their potential positive effects in wound Contents healing, Kaposi sarcoma, melanoma and pyogenic granuloma, and, more recently, pemphigus. Since β-blockers are deployed 1. Introduction in a variety of disorders, which have cutaneous co-morbidities 2. Cutaneous side - effects of β-blockers such as psoriasis, their pertinence to dermatologists cannot be 3.
    [Show full text]
  • Copyrighted Material
    Part 1 General Dermatology GENERAL DERMATOLOGY COPYRIGHTED MATERIAL Handbook of Dermatology: A Practical Manual, Second Edition. Margaret W. Mann and Daniel L. Popkin. © 2020 John Wiley & Sons Ltd. Published 2020 by John Wiley & Sons Ltd. 0004285348.INDD 1 7/31/2019 6:12:02 PM 0004285348.INDD 2 7/31/2019 6:12:02 PM COMMON WORK-UPS, SIGNS, AND MANAGEMENT Dermatologic Differential Algorithm Courtesy of Dr. Neel Patel 1. Is it a rash or growth? AND MANAGEMENT 2. If it is a rash, is it mainly epidermal, dermal, subcutaneous, or a combination? 3. If the rash is epidermal or a combination, try to define the SIGNS, COMMON WORK-UPS, characteristics of the rash. Is it mainly papulosquamous? Papulopustular? Blistering? After defining the characteristics, then think about causes of that type of rash: CITES MVA PITA: Congenital, Infections, Tumor, Endocrinologic, Solar related, Metabolic, Vascular, Allergic, Psychiatric, Latrogenic, Trauma, Autoimmune. When generating the differential, take the history and location of the rash into account. 4. If the rash is dermal or subcutaneous, then think of cells and substances that infiltrate and associated diseases (histiocytes, lymphocytes, mast cells, neutrophils, metastatic tumors, mucin, amyloid, immunoglobulin, etc.). 5. If the lesion is a growth, is it benign or malignant in appearance? Think of cells in the skin and their associated diseases (keratinocytes, fibroblasts, neurons, adipocytes, melanocytes, histiocytes, pericytes, endothelial cells, smooth muscle cells, follicular cells, sebocytes, eccrine
    [Show full text]
  • Copyrighted Material
    1 Index Note: Page numbers in italics refer to figures, those in bold refer to tables and boxes. References are to pages within chapters, thus 58.10 is page 10 of Chapter 58. A definition 87.2 congenital ichthyoses 65.38–9 differential diagnosis 90.62 A fibres 85.1, 85.2 dermatomyositis association 88.21 discoid lupus erythematosus occupational 90.56–9 α-adrenoceptor agonists 106.8 differential diagnosis 87.5 treatment 89.41 chemical origin 130.10–12 abacavir disease course 87.5 hand eczema treatment 39.18 clinical features 90.58 drug eruptions 31.18 drug-induced 87.4 hidradenitis suppurativa management definition 90.56 HLA allele association 12.5 endocrine disorder skin signs 149.10, 92.10 differential diagnosis 90.57 hypersensitivity 119.6 149.11 keratitis–ichthyosis–deafness syndrome epidemiology 90.58 pharmacological hypersensitivity 31.10– epidemiology 87.3 treatment 65.32 investigations 90.58–9 11 familial 87.4 keratoacanthoma treatment 142.36 management 90.59 ABCA12 gene mutations 65.7 familial partial lipodystrophy neutral lipid storage disease with papular elastorrhexis differential ABCC6 gene mutations 72.27, 72.30 association 74.2 ichthyosis treatment 65.33 diagnosis 96.30 ABCC11 gene mutations 94.16 generalized 87.4 pityriasis rubra pilaris treatment 36.5, penile 111.19 abdominal wall, lymphoedema 105.20–1 genital 111.27 36.6 photodynamic therapy 22.7 ABHD5 gene mutations 65.32 HIV infection 31.12 psoriasis pomade 90.17 abrasions, sports injuries 123.16 investigations 87.5 generalized pustular 35.37 prepubertal 90.59–64 Abrikossoff
    [Show full text]
  • What Is the Biological Basis of Pattern Formation of Skin Lesions?
    Experimental Dermatology 2006: 15: 547–564 Copyright Ó The Authors 2006. Journal compilation Ó 2006 Blackwell Munksgaard Blackwell Munksgaard . Printed in Singapore Experimental Dermatology ISSN 0906-6705 Controversies in Experimental Dermatology Section Editor: Ralf Paus, Lu¨beck What is the biological basis of pattern formation of skin lesions? Chuong CM, Dhouailly D, Gilmore S, Forest L, Shelley WB, Stenn KS, Maini P, C. M. Chuong, D. Dhouailly, S. Gilmore, Michon F, Parimoo S, Cadau S, Demongeot J, Zheng Y, Paus R, Happle R. What L. Forest, W. B. Shelley, K. S. Stenn, is the biological basis of pattern formation of skin lesions? P. Maini, F. Michon, S. Parimoo, Exp Dermatol 2006: 15: 547–564. Ó The Authors 2006. Journal compilation S. Cadau, J. Demongeot, Y. Zheng, Ó 2006 Blackwell Munksgaard. R. Paus and R. Happle Abstract: Pattern recognition is at the heart of clinical dermatology and dermato- pathology. Yet, while every practitioner of the art of dermatological diagnosis recognizes the supreme value of diagnostic cues provided by defined patterns of ‘efflorescences’, few contemplate on the biological basis of pattern formation in and of skin lesions. Vice versa, developmental and theoretical biologists, who would be best prepared to study skin lesion patterns, are lamentably slow to discover this field as a uniquely instructive testing ground for probing theoretical concepts on pattern generation in the human system. As a result, we have at best scraped the surface of understanding the biological basis of pattern formation of skin lesions, and widely open questions dominate over definitive answer. As a sym- metry-breaking force, pattern formation represents one of the most fundamental principles that nature enlists for system organization.
    [Show full text]
  • Nail Disorders in Dark Skin 34 Moetaz El-Domyati and Noha H
    Nail Disorders in Dark Skin 34 Moetaz El-Domyati and Noha H. Moftah The nail unit is a skin appendage produced by the skin. Its painful paronychia result, occasionally, with pus-filled small major function is mechanical protection of the distal digit, abscesses. Chronic paronychia may be painful and show peri- also representing a part of the overall cosmetic appearance of odic flare-ups in labor workers, after exposure to chemicals the body. Genetic disorders, infections, various dermatoses, and other irritants, etc. Treatment is by warm soaks with senility, tumors, etc. may result in a series of changes of the water, liquid antibacterial soaps, and topical antibiotics; in nail showing alterations of growth, color, thickness, and con- severe cases oral antibiotics may be required. If a paronychial tour of the nail plate. Thus, examination of the digits and abscess is diagnosed, surgical drainage is indicated [2]. nails often provides diagnostic clues for underlying cutane- ous or systemic disease. Alterations and deformities of the nails may be characteristic and helpful for the physician to 34.1.2 Fungal Infections support his diagnosis; others are not specific but still provide valuable clues for targeted medical investigation. Major dif- Infection of the nails with dermatophytes, Tinea (T.) ferences of nail pathology between Caucasians and dark- unguium is common both in white Caucasians and in pop- skinned ethnic populations are not known or prominent; ulations with darkly pigmented skin. The average preva- however, environmental exposure and socioeconomic cir- lence in fair skin populations in Europe and North America cumstances in populations living in hot climate zones differ is approximately 4% [3, 4] and up to 5.5–10% in popula- and cause differences in the clinical presentation and medi- tions with dark skin [5].
    [Show full text]
  • Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
    92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, ␤3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣6␤4 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1
    [Show full text]
  • A Deep Learning System for Differential Diagnosis of Skin Diseases
    A deep learning system for differential diagnosis of skin diseases 1 1 1 1 1 1,2 † Yuan Liu ,​ Ayush Jain ,​ Clara Eng ,​ David H. Way ,​ Kang Lee ,​ Peggy Bui ,​ Kimberly Kanada ,​ ​ ​ ‡ ​ 1​ ​ 1 ​ 1 ​ Guilherme de Oliveira Marinho ,​ Jessica Gallegos ,​ Sara Gabriele ,​ Vishakha Gupta ,​ Nalini 1,3,§ 1 ​ ​ 4 ​ 1 ​ ​ 1 Singh ,​ Vivek Natarajan ,​ Rainer Hofmann-Wellenhof ,​ Greg S. Corrado ,​ Lily H. Peng ,​ Dale ​ ​ 1 1 ​ † 1, ​ 1, ​ 1, ​ R. Webster ,​ Dennis Ai ,​ Susan Huang ,​ Yun Liu *​ , R. Carter Dunn *​ *, David Coz *​ * ​ ​ ​ ​ ​ ​ Affiliations: 1 G​ oogle Health, Palo Alto, CA, USA 2 U​ niversity of California, San Francisco, CA, USA 3 M​ assachusetts Institute of Technology, Cambridge, MA, USA 4 M​ edical University of Graz, Graz, Austria † W​ ork done at Google Health via Advanced Clinical. ‡ W​ ork done at Google Health via Adecco Staffing. § W​ ork done at Google Health. *Corresponding author: [email protected] **These authors contributed equally to this work. Abstract Skin and subcutaneous conditions affect an estimated 1.9 billion people at any given time and remain the fourth leading cause of non-fatal disease burden worldwide. Access to dermatology care is limited due to a shortage of dermatologists, causing long wait times and leading patients to seek dermatologic care from general practitioners. However, the diagnostic accuracy of general practitioners has been reported to be only 0.24-0.70 (compared to 0.77-0.96 for dermatologists), resulting in over- and ​ ​ ​ ​ ​ ​ ​ under-referrals, delays in care, and errors in diagnosis and treatment. In this paper, we developed a deep learning system (DLS) to provide a differential diagnosis of skin conditions for clinical cases (skin photographs and associated medical histories).
    [Show full text]
  • Science of the Nail Apparatus David A.R
    1 CHAPTER 1 Science of the Nail Apparatus David A.R. de Berker 1 and Robert Baran 2 1 Bristol Dermatology Centre , Bristol Royal Infi rmary , Bristol , UK 2 Nail Disease Center, Cannes; Gustave Roussy Cancer Institute , Villejuif , France Gross anatomy and terminology, 1 Venous drainage, 19 Physical properties of nails, 35 Embryology, 3 Effects of altered vascular supply, 19 Strength, 35 Morphogenesis, 3 Nail fold vessels, 19 Permeability, 35 Tissue differentiation, 4 Glomus bodies, 20 Radiation penetration, 37 Factors in embryogenesis, 4 Nerve supply, 21 Imaging of the nail apparatus, 37 Regional anatomy, 5 Comparative anatomy and function, 21 Radiology, 37 Histological preparation, 5 The nail and other appendages, 22 Ultrasound, 37 Nail matrix and lunula, 7 Phylogenetic comparisons, 23 Profi lometry, 38 Nail bed and hyponychium, 9 Physiology, 25 Dermoscopy (epiluminescence), 38 Nail folds, 11 Nail production, 25 Photography, 38 Nail plate, 15 Normal nail morphology, 27 Light, 40 Vascular supply, 18 Nail growth, 28 Other techniques, 41 Arterial supply, 18 Nail plate biochemical analysis, 31 Gross anatomy and terminology with the ventral aspect of the proximal nail fold. The intermediate matrix (germinative matrix) is the epithe- Knowledge of nail unit anatomy and terms is important for lial structure starting at the point where the dorsal clinical and scientific work [1]. The nail is an opalescent win- matrix folds back on itself to underlie the proximal nail. dow through to the vascular nail bed. It is held in place by The ventral matrix is synonymous with the nail bed the nail folds, origin at the matrix and attachment to the nail and starts at the border of the lunula, where the inter- bed.
    [Show full text]
  • Atlas of DISEASES of the NAIL
    An Atlas of DISEASES OF THE NAIL THE ENCYCLOPEDIA OF VISUAL MEDICINE SERIES An Atlas of DISEASES OF THE NAIL Phoebe Rich, MD Oregon Health Sciences University Portland, Oregon, USA Richard K.Scher, MD College of Physicians and Surgeons Columbia University, New York, USA The Parthenon Publishing Group International Publishers in Medicine, Science & Technology A CRC PRESS COMPANY BOCA RATON LONDON NEW YORK WASHINGTON, D.C. Published in the USA by The Parthenon Publishing Group Inc. 345 Park Avenue South, 10th Floor New York NY 10010 USA This edition published in the Taylor & Francis e-Library, 2005. To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk. Published in the UK and Europe by The Parthenon Publishing Group 23–25 Blades Court Deodar Road London SW15 2NU UK Copyright © 2003 The Parthenon Publishing Group Library of Congress Cataloging-in-Publication Data Rich, Phoebe An atlas of diseases of the nail/Phoebe Rich, R.K.Scher p.; cm.—(The encyclopedia of visual medicine series) Includes bibliographical references and index. ISBN 1-85070-595-X 1. Nails (Anatomy)—Diseases—Atlases. I. Title: Diseases of the nail. II. Rich, Phoebe III. Title. IV. Series. [DNLM: 1. Nail Diseases—diagnosis—Atlases. 2. Nail Diseases—therapy—Atlases. WR 17 S326a 2002] RL165.S35 2002 616.5′47—dc21 2002025346 British Library Cataloguing in Publication Data Rich, Phoebe— An atlas of diseases of the nail 1. Nails (Anatomy)—Diseases I. Title II. Scher, Richard K., 1929– 616.5′47 ISBN 0-203-49069-X Master e-book ISBN ISBN 0-203-59671-4 (Adobe eReader Format) ISBN 1-85070-595-X (Print Edition) First published in 2003 This edition published in the Taylor & Francis e-Library, 2005.
    [Show full text]